DiGeorge Anomaly

Also known as: DiGeorge Syndrome / 22q11.2 Deletion Syndrome / DiGeorge's syndrome / Di George's syndrome / 22q11.2 deletion syndrome (disorder) / Thymic-parathyroid aplasia / Velo-cardio-facial syndrome / Velocardiofacial Syndrome

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB13906Aloe vera leaf1Terminated1
DB00126Ascorbic acid1Terminated1
DB09462Glycerin1Terminated1
DB02701Nicotinamide1Terminated1
DB00162Vitamin A1Terminated1
DB00098Antithymocyte immunoglobulin (rabbit)1 / 2Completed1
DB00091Cyclosporine1 / 2Completed1
DB00111Daclizumab1 / 2Completed1
DB00959Methylprednisolone1 / 2Completed1
DB00688Mycophenolate mofetil1 / 2Completed1
DB00860Prednisolone1 / 2Completed1
DB00864Tacrolimus1 / 2Completed1
DB00087Alemtuzumab2Recruiting1
DB01073Fludarabine2Recruiting1
DB01042Melphalan2Recruiting1
DB12716NB-0012Completed1
DB08839Serotonin2Not Yet Recruiting1
DB01104Sertraline2Not Yet Recruiting1
DB04572Thiotepa2Recruiting1
DB06285Teriparatide3Terminated1
DB00091CyclosporineNot AvailableApproved for Marketing1
DB00422MethylphenidateNot AvailableCompleted1
DB00959MethylprednisoloneNot AvailableApproved for Marketing1
DB00688Mycophenolate mofetilNot AvailableApproved for Marketing1
DB00860PrednisoloneNot AvailableApproved for Marketing1
DB00734RisperidoneNot AvailableTerminated1
DB00864TacrolimusNot AvailableApproved for Marketing1